Boston Taiwanese Biotechnology Association


BTBA logo

Boston Taiwanese Biotechnology Association (BTBA) is a non-profit organization started in 2012 by a group of Taiwanese graduate students, postdocs and young professionals in the greater Boston area. Our goals are to foster individual career development, to enhance scientific collaborations, to facilitate interactions and to strengthen networking among academic and industrial bioscience communities in Taiwan and US.


Event

Academic Seminar

Emerging Therapeutic Opportunities for AI-powered Protein Design

2025-03-01, 12-3 PM ET
Fong Auditorium, Harvard University
BTBA

Register here

Career Development Series

Building and Implementing the Business Mindset for Your Career

2025-01-26, 1-2:30 PM ET
Emerson Hall 305 (29 Quincy St, Cambridge, MA)
BTBA

Register here


Meet People, Catch Up With Friends, And Learn


Academic Seminar

2030跨世代年輕學者 X 玉山青年學者海外說明會

2024-12-18, 8-10 PM ET
Virtual
BTBA

Register here

Career Development Series

JTBA x BTBA 交流會:美日生技大哉問

2024-12-13, 7-9 PM ET
Virtual
BTBA, JTBA

Register here


Podcast


S5 EP12:好友聊聊天:一個電機人的基因體學之旅 ft. 陳乃群 🎧

Mar 15, 2025

在當前的科技與生技領域,計算基因組學正逐漸成為一項重要的研究方向。然而,若是你,什麼原因會促使你選擇從一位炙手可熱的電機工程師,轉向生命科學的探索?這樣的轉變對許多人來說並不常見,但對陳乃群博士 ...More info


S5 EP11:AI 藥物開發系列|Insilico Medicine ft. 林彥竹博士 🎧

Mar 01, 2025

人工智慧(AI)如何改變藥物開發?藥物開發從臨床前研究到臨床試驗,通常需要超過十年時間和數十億美元的投資,卻仍有高達九成的藥物在臨床試驗中失敗。這些挑戰,現在 AI 正在各種方面掀起革命。在這系 ...More info


S5 EP.10:智慧膠囊──開創壓力監測新時代 ft. 廖建宏醫師 🎧

Feb 15, 2025

腹腔壓力異常 (Intra-abdominal Hypertension, IAH) 是重症病房 (ICU) 患者常見但監測率極低的問題。估計超過 60% 的 ICU 病人可能有腹腔壓力過高的問 ...More info


Blog


腦與神經科學

腦與神經科學系列:藥廠神經藥物開發的現況觀察與前景.黃正球博士 (Dr. Cheng-Chiu (Joe) Huang).訪談摘要

By 文:林書弘.圖:陳政儀.編輯:劉駿 on Nov, 2024

在《生技來一刻》第四季第十二集的訪談中,主持人奕芸邀請到了黃正球博士(Joe),現任Eli Lilly神經科學部門的高階主管,來分享他在神經藥物研發領域的經驗與見解。 黃博士擁有豐富的學術背景與業界經歷,從臺灣大學動物系畢業後一路深造,最終在美國加入生技與製藥產業,專注於神經疾病的藥物開發。這次訪談深入探討了神經科學領域的現況與未來趨勢,對生技業界尤其是從事神經科學的聽眾提供了許多寶貴的洞見。 ...Read more


商業與策略

藥廠投資組合管理.羅盈智醫師 (Dr. Ying-Chih (Paul) Lo).訪談摘要

By 文:林書弘.圖:陳政儀.編輯:劉駿 on Apr, 2024

在現今的生技產業中,投資組合管理與數據分析技術的重要性日益增加。尤其在藥物開發這一高風險領域,有效的策略和先進的技術可以顯著提升研發的成功率及市場競爭力。透過近期與羅盈智醫師(Paul)的對話,我們得以深入了解這些策略如何在實際應用中發揮作用。 Paul目前在美國波士頓的 Novartis 藥廠擔任 Portfolio Data Science 部門的副總監,同時也是波士頓台灣醫師協會的會長。他的職業生涯跨越了醫療、人工智慧和商業策略,這使他對於藥廠如何進行投資組合管理有著獨到的見解。 ...Read more


Sneak peek into the industry

Po-Jen (Will) Yen, Business Development

By Yi-Shan Chen on Mar, 2019

As a scientist in Biotech/Pharma, Business Development to me is a function that usually doesn’t have a lot of interaction with researchers unless they need data from you but the decisions they make influence researchers the most. ...Read more


Sneak peek into the industry

TeYu Chen, Medicinal Chemist

By Yi-ying Chou on Nov, 2018

I always thought that doing biological experiments, like sitting long hours in front of tissue culture hood, can be physically challenging. When I chat with Ryan, I realized that medicinal chemists also have heavy workload on the bench side. In pharmaceutical company, chemists are not allowed to be ...Read more